226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
540.27%
Net income growth above 1.5x JD's 10.51%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
9.16%
D&A growth of 9.16% while JD is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-111.66%
Negative yoy deferred tax while JD stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
111.66%
SBC growth of 111.66% while JD is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
760.38%
Working capital change of 760.38% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
161.65%
AR growth of 161.65% while JD is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-54.72%
Negative yoy inventory while JD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
343.79%
AP growth of 343.79% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
110.78%
Growth of 110.78% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-3605.58%
Both negative yoy, with JD at -301.39%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
378.00%
Some CFO growth while JD is negative at -173.37%. John Neff would note a short-term liquidity lead over the competitor.
-27.97%
Negative yoy CapEx while JD is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-17.71%
Negative yoy purchasing while JD stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
6.15%
Liquidation growth of 6.15% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
23.45%
Lower net investing outflow yoy vs. JD's 230.06%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-1.64%
We cut debt repayment yoy while JD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
118.64%
Issuance growth of 118.64% while JD is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.